Edesa Biotech Inc., of Toronto, said the previously disclosed business combination with Stellar Biotechnologies Inc., of Port Hueneme, Calif., which was completed pursuant to a share exchange agreement, has closed. The combined company will focus on the development and advancement of treatments for dermatological and gastrointestinal indications. It will go under the Edesa name and will commence trading Monday on Nasdaq under the ticker EDSA.